| Mackenzie Mullen Ross, NP | |
|
165 Lancaster St, Portland, ME 04101-2406 | |
| (207) 874-1030 | |
| (207) 874-1044 |
| Full Name | Mackenzie Mullen Ross |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 165 Lancaster St, Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033627237 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reliant Medical Group Inc | 5597755322 | 543 |
News Archive
An epilepsy drug shows promise in an animal model at preventing tinnitus from developing after exposure to loud noise, according to a new study by researchers at the University of Pittsburgh School of Medicine.
Johns Hopkins Medicine researchers report they have developed an experimental laboratory test that accurately clocks the "speed" of human brain tumor cell movement along a small glass "track."
In an article in Brain, researchers at the Medical University of South Carolina (MUSC) and elsewhere report which brain regions must be intact in stroke survivors with aphasia if they are to perform well in a speech entrainment session, successfully following along with another speaker.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
› Verified 4 days ago
| Entity Name | Reliant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
An epilepsy drug shows promise in an animal model at preventing tinnitus from developing after exposure to loud noise, according to a new study by researchers at the University of Pittsburgh School of Medicine.
Johns Hopkins Medicine researchers report they have developed an experimental laboratory test that accurately clocks the "speed" of human brain tumor cell movement along a small glass "track."
In an article in Brain, researchers at the Medical University of South Carolina (MUSC) and elsewhere report which brain regions must be intact in stroke survivors with aphasia if they are to perform well in a speech entrainment session, successfully following along with another speaker.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mackenzie Mullen Ross, NP 165 Lancaster St, Portland, ME 04101-2406 Ph: (207) 874-1030 | Mackenzie Mullen Ross, NP 165 Lancaster St, Portland, ME 04101-2406 Ph: (207) 874-1030 |
News Archive
An epilepsy drug shows promise in an animal model at preventing tinnitus from developing after exposure to loud noise, according to a new study by researchers at the University of Pittsburgh School of Medicine.
Johns Hopkins Medicine researchers report they have developed an experimental laboratory test that accurately clocks the "speed" of human brain tumor cell movement along a small glass "track."
In an article in Brain, researchers at the Medical University of South Carolina (MUSC) and elsewhere report which brain regions must be intact in stroke survivors with aphasia if they are to perform well in a speech entrainment session, successfully following along with another speaker.
Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.
› Verified 4 days ago
Ms. Nicole L. Mizner, C.P.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 887 Congress St, Suite 310, Portland, ME 04102 Phone: 207-773-2723 Fax: 207-773-3941 | |
Patricia Mae Wieler, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 818 Congress St, Portland, ME 04102 Phone: 207-773-8161 | |
Olivia Polise, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Ms. Kelly Irene Daly, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 51 Sewall St Ste 1, Portland, ME 04102 Phone: 207-774-5761 Fax: 207-874-7478 | |
Katharine E Addicott, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2911 Fax: 207-662-6006 | |
Leah Victoria Mahoney, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 66 Bramhall St, Portland, ME 04102 Phone: 207-662-3157 Fax: 207-662-4257 | |
Lucy A Mack, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 161 Marginal Way, Portland, ME 04101 Phone: 207-773-7964 |